CalciMedica Inc reports results for the quarter ended March 31 - Earnings Summary

• CalciMedica Inc CALC.OQ reported a quarterly adjusted loss of 36 cents​​ per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of 1 cents. The mean expectation of three analysts for the quarter was for a loss of 31 cents per share. Wall Street expected results to range from -43 cents to -14 cents per share.

• Reported revenue was zero​; analysts expected zero.

• CalciMedica Inc's reported EPS for the quarter was a loss of 36 cents​.

• The company reported a quarterly loss of $5.04 million.

• CalciMedica Inc shares had risen by 1.0% this quarter and lost 45.5% so far this year.

FORECAST CHANGES

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for CalciMedica Inc is $15.50

This summary was machine generated from LSEG data May 14 at 11:59 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)